Investor profile
Macmillan Cancer Support has backed 3 European tech companies across 3 funding rounds between 2025 and 2026, joining rounds totalling €21M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxcan | UK | 1 | €11M |
| Lucida Medical | UK | 1 | €10M |
| Dxcover | UK | 1 | €0 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxcan | Series A | €11M | 2025-01 |
| Lucida Medical | Other | €10M | 2026-03 |
